SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study | Zendy

Matthew Brams | Zendy; Ann Childress | Zendy; Michael Greenbaum | Zendy; Ming Yu | Zendy; Brian Yan | Zendy; Margo Jaffee | Zendy; Brigitte Robertson | Zendy

Open Access

SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study

Author(s) -

Matthew Brams,

Ann Childress,

Michael Greenbaum,

Ming Yu,

Brian Yan,

Margo Jaffee,

Brigitte Robertson

Publication year - 2017

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2017.0053

Subject(s) - tolerability , placebo , attention deficit hyperactivity disorder , adverse effect , randomized controlled trial , clinical endpoint , medicine , confidence interval , psychology , psychiatry , alternative medicine , pathology

The aim of this study was to evaluate the efficacy, safety, and tolerability of SHP465 mixed amphetamine salts (MAS) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research